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Syntrophins are cytoplasmic peripheral membrane proteins of
the dystrophin-associated protein complex (DAPC). Three syn-
trophin isoforms, a1, b1, and b2, are encoded by distinct
genes. Each contains two pleckstrin homology (PH) domains, a
syntrophin-unique (SU) domain, and a PDZ domain. The name
PDZ comes from the first three proteins found to contain re-
peats of this domain (PSD-95, Drosophila discs large protein,
and the zona occludens protein 1). PDZ domains in other
proteins bind to the C termini of ion channels and neurotrans-
mitter receptors containing the consensus sequence (S/T)XV-
COOH and mediate the clustering or synaptic localization of
these proteins. Two voltage-gated sodium channels (NaChs),
SkM1 and SkM2, of skeletal and cardiac muscle, respectively,
have this consensus sequence. Because NaChs are sarcolem-
mal components like syntrophins, we have investigated possi-
ble interactions between these proteins. NaChs copurify with
syntrophin and dystrophin from extracts of skeletal and cardiac
muscle. Peptides corresponding to the C-terminal 10 amino
acids of SkM1 and SkM2 are sufficient to bind detergent-
solubilized muscle syntrophins, to inhibit the binding of native
NaChs to syntrophin PDZ domain fusion proteins, and to bind
specifically to PDZ domains from a1-, b1-, and b2-syntrophin.
These peptides also inhibit binding of the syntrophin PDZ
domain to the PDZ domain of neuronal nitric oxide synthase, an
interaction that is not mediated by C-terminal sequences. Brain
NaChs, which lack the (S/T)XV consensus sequence, also co-
purify with syntrophin and dystrophin, an interaction that does
not appear to be mediated by the PDZ domain of syntrophin.
Collectively, our data suggest that syntrophins link NaChs to
the actin cytoskeleton and the extracellular matrix via dystro-
phin and the DAPC.
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To receive and transduce chemical signals from motor neurons,
skeletal muscle cells have developed a complex, highly organized
postsynaptic membrane. The hallmark of this specialization is the
very high concentrations (;10,000/mm2) of nicotinic acetylcho-
line receptors (AChRs) at the crests of the postsynaptic folds
(Fertuck and Salpeter, 1974). Voltage-gated sodium channels
(NaChs) are also concentrated in the postsynaptic membrane,
where they are primarily confined to the deeper portions of the
folds, and in the perijunctional membrane (Betz et al., 1984;
Beam et al., 1985; Angelides, 1986; Caldwell et al., 1986; Haimov-
ich et al., 1987; Flucher and Daniels, 1989). This uneven distri-
bution may result in part from a gradient of NaCh expression by
muscle nuclei along the muscle fiber. Locally, however, it seems
most likely to involve NaCh anchoring by cytoskeletal or other
elements (Lupa and Caldwell, 1994).
Compared with the wealth of data on AChR clustering, little is
known about the mechanism of anchoring of NaChs. The synap-
tic accumulation of AChRs in skeletal muscle involves the asso-
ciation of AChRs with the postsynaptic cytoskeleton in response
to signals initiated by neurally derived agrin (McMahan, 1990;
Bowe and Fallon, 1995). The 43 kDa AChR-associated protein
rapsyn is believed to play a central role in this process. Rapsyn
clusters AChRs in heterologous cells (Froehner et al., 1990;
Phillips et al., 1991) and in rapsyn-deficient mice, AChRs are
distributed diffusely and do not cluster in response to exogenously
applied agrin (Gautam et al., 1995). Recently, NaChs have been
shown to aggregate at points of contact between skeletal muscle
cells and Chinese hamster ovary (CHO) cells expressing a neural
form of agrin, suggesting that similar mechanisms mediate NaCh
anchoring (Sharp and Caldwell, 1996). However, a cytoskeletal
protein with a function analogous to rapsyn has yet to be identi-
fied for NaChs.
The syntrophins are a family of intracellular peripheral mem-
brane proteins that are components of the dystrophin-associated
protein complex (DAPC) in skeletal muscle. The three known
syntrophin isoforms, a1, b1, and b2, are encoded by separate
genes and are differentially expressed. All three isoforms are
expressed in skeletal muscle, although a1-syntrophin is the most
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abundant (Adams et al., 1993, 1995; Ahn et al., 1994; Yang et al.,
1994). Each syntrophin has two tandem pleckstrin homology
(PH) domains followed by a C-terminal syntrophin-unique (SU)
domain (Adams et al., 1995). Inserted in the first PH domain is a
single PDZ domain. The name PDZ comes from the first three
proteins found to contain repeats of this domain (PSD-95, Dro-
sophila discs large protein, and the zona occludens protein 1)
(Cho et al., 1992). In skeletal muscle, a1- and b1-syntrophin are
found on the sarcolemma and are relatively concentrated at the
neuromuscular junction (NMJ), whereas b2-syntrophin is con-
centrated at the NMJ but barely detectable on the sarcolemma
(Peters et al., 1994, 1997). Syntrophins bind directly to the
C-terminal domain of dystrophin and the dystrophin-related pro-
teins utrophin and dystrobrevin (Kramarcy et al., 1994; Ahn and
Kunkel, 1995; Dwyer and Froehner, 1995; Yang et al., 1995; Ahn
et al., 1996). The absence of dystrophin in Duchenne muscular
dystrophy (DMD) and the mdx mouse leads to a dramatic reduc-
tion in sarcolemmal syntrophin, although the syntrophins remain
concentrated at the NMJ (Butler et al., 1992; Peters et al. 1994,
1997; Yang et al., 1995).
The PDZ domain of a1-syntrophin is known to bind to the
PDZ-containing N-terminal region of neuronal nitric oxide syn-
thase (nNOS), thereby targeting the enzyme to the sarcolemma
(Brenman et al., 1996a). In other proteins, PDZ domains bind to
the C termini of proteins containing the consensus sequence
(S/T)XV-COOH, an interaction that has been shown to mediate
clustering of NMDA receptors and shaker family K1 channels by
the PSD-95 family of synapse-associated proteins (Kim et al.,
1995, 1996; Kornau et al., 1995). We investigated the possibility
that syntrophins bind to ion channels via their PDZ domains. In
particular, the a subunits of two skeletal muscle NaChs, SkM1
and SkM2/rH1 (hereafter referred to as SkM2), have C-terminal
sequences with the (S/T)XV motif, and NaChs, like syntrophins,
are present on the sarcolemma and are concentrated at the NMJ
(Froehner et al., 1987; Flucher and Daniels, 1989). We found that
syntrophins, dystrophin, and NaChs can be isolated as stable
complexes from detergent extracts of skeletal and cardiac muscle,
and that the PDZ domains of all three syntrophins bind the
C-terminal sequences of SkM1 and SkM2. Brain NaChs, which
lack the C-terminal (S/T)XV consensus sequence, can also be
isolated in a complex with syntrophins and dystrophin. This
interaction does not appear to be mediated by the PDZ domains
of syntrophins. Our data suggest that syntrophins link NaChs to
the actin cytoskeleton and the extracellular matrix via dystrophin
and the DAPC.
MATERIALS AND METHODS
Antisera. Affinity-purified polyclonal antibodies to NaChs were prepared
and characterized as described previously (Dugandzija-Novakovic et al.,
1995). In brief, antisera were raised against a synthetic 18-mer peptide
(TEEQKKYYNAMKKLGSKK) corresponding to a putative intracel-
lular loop connecting homology domains III and IV, a region that is
highly conserved in all functional vertebrate NaChs. The preparation
and characterization of the anti-syntrophin monoclonal antibody (mAb)
1351 has been described previously (Froehner et al., 1987). mAb 1351 is
directed against an epitope within the PDZ domain of syntrophin (S. H.
Gee and S. C. Froehner, unpublished data) and recognizes all known
mouse syntrophin isoforms (Peters et al., 1994, 1997). mAb 1808 against
dystrophin has been described previously (Sealock et al., 1991). Isoform-
specific monoclonal antibodies to K 1 channel a subunits (Bekele-Arcuri
et al., 1996) were a generous gift from Dr. James S. Trimmer (State
University of New York at Stony Brook).
Fusion proteins. Mouse a1-syntrophin domains were generated by PCR
amplification of an a1-syntrophin cDNA clone (GenBank accession
number U00677) with oligonucleotide primers flanking nucleotides 111–
341 (PH1a), 333–620 (PDZ), 594–923 (PH1b), 948–1328 (PH2), and
1323–1622 (SU) (Adams et al., 1993; Brenman et al., 1996a). For the
b2-PDZ domain, the primers flanked nucleotides 320–594 (correspond-
ing to amino acids 90–184) of a cDNA encoding mouse b2-syntrophin
(GenBank accession number U00678) (Adams et al., 1993). For the b1-
PDZ domain, the primers flanked nucleotides 667–954 (corresponding to
amino acids 115–210) of a cDNA encoding mouse b1-syntrophin (GenBank
accession number U89997) (Peters et al. 1997). The resultant products were
subcloned into the pET-32a vector (Novagen, Madison, WI) that contains
sequences encoding thioredoxin, an N-terminal 15 amino acid S-Tag, and a
hexahistidine nickel binding motif. The 39 end of the PH1a PCR product
was ligated to the 59 end of the PH1b PCR product (using engineered XbaI
sites) to produce an intact PH1 domain. Positive clones were selected and
sequenced. Clones with the correct sequence were electroporated into
BL21(lDE3)pLysS competent cells. Overnight cultures were diluted 1:10,
grown at 37°C for 2 hr, and then induced for 17 hr at 28°C with 1 mM
isopropyl-b-D-thiogalactopyranoside. The expressed fusion proteins were
all recognized by the S-Protein HRP conjugate (Novagen) and were puri-
fied on nickel-Sepharose columns according to the manufacturer’s instruc-
tions. All domains were purified from the soluble fraction. Fusion protein
purity was determined by Coomassie blue staining of SDS-polyacrylamide
gels. Protein concentration was determined by the method of Bradford
(1976). Fusion proteins linking N-terminal domains of nNOS (amino acids
1–150 and 1–299) and glutathione S-transferase (GST) were generated as
described (Brenman et al., 1996a,b).
Peptides. Synthetic peptides corresponding to the C-terminal 10 amino
acids of the adult skeletal muscle NaCh (SkM1; VRPGVKESLV), the
cardiac and embryonic skeletal muscle NaCh (SkM2; SPDRDRESIV),
and the NMDA receptor 2B subunit (NR2B; EKLSSIESDV) were
purchased from Macromolecular Resources (Colorado State University,
Fort Collins, CO). Fas (NFRNEIQLSLV) and adenomatous polyposis
coli (APC; HSGSYLVTSV) peptides were a generous gift from Dr.
Brian Kay and Stacy Sekely (University of North Carolina at Chapel
Hill). All peptides contained an additional four amino acid linker
(SGSG) at the N terminus and an N-terminal biotin.
Preparation of detergent-solubilized membrane extracts. Tissues were
dissected from C57BL6 mice or Sprague Dawley rats and were frozen in
liquid nitrogen or used fresh as needed. Tissue was homogenized in a
Waring blender in 10 vol of 50 mM Tris, pH 7.5, 1 mM EDTA, and 1 mM
EGTA (TEE). The following protease inhibitors were added immedi-
ately before homogenization: 1 mM phenylmethylsulfonyl fluoride and 1
mg/ml each leupeptin, pepstatin, aprotinin, and antipain. The homoge-
nate was centrifuged at 30,000 3 g for 10 min, and the supernatant was
removed. The pellet was rehomogenized in 10 vol of the same buffer and
then centrifuged as above. The final pellet was resuspended in 10 vol of
TEE plus 100 mM NaCl plus 1% Triton X-100, extracted for 30 min at
4°C on a rocker platform, and then clarified by centrifuging at 40,000 3
g for 20 min. The supernatant was removed from beneath the fat layer, if
present.
Peptide affinity chromatography. Biotinylated SkM1, SkM2, and NR2B
peptides (200 mg each) were coupled to 0.5 ml of streptavidin–agarose
(Sigma, St. Louis, MO) in PBS, pH 7.2, for 5 hr at 4°C on a rocker
platform. The beads were then washed extensively with TEE plus 350 mM
NaCl plus 0.1% Triton X-100 to remove unbound peptide. Two hundred
microliters of a 50% slurry of each agarose-coupled peptide or of uncou-
pled streptavidin–agarose beads were added to 1 ml of detergent-
solubilized cardiac muscle membranes and incubated overnight at 4°C on
a rocker platform. After extensive washing with the above buffer, the
beads were aspirated to near dryness and heated to 80°C in 100 ml of
SDS-PAGE loading buffer.
Immunoaffinity purification. mAb 1351 against syntrophin, mAb 1808
against dystrophin, and control mouse IgG (4 mg each) were coupled to
Affi-Gel 10 (Bio-Rad, Hercules, CA) in 20 mM HEPES, pH 7.5, plus 150
mM NaCl according to the manufacturer’s instructions. These antibody
resins were incubated with 10 ml of detergent-solubilized membranes for
1 hr at 4°C and then were washed extensively with TEE plus 0.5 M NaCl
plus 1% Triton X-100, followed by washing with TEE plus 0.5 M NaCl
plus 0.1% Triton X-100 and finally with TEE. Bound proteins were
eluted with 2.75 ml of 0.1 M triethylamine, pH 11.5, and were immedi-
ately neutralized by the addition of 1.25 ml of 1.5 M Tris, pH 6.8. Eluted
proteins were precipitated by the addition of 0.5 ml 100% trichloroacetic
acid (TCA; final concentration, 12%) and overnight incubation on ice.
Proteins were pelleted by centrifugation at 39,000 3 g for 1 hr in an
SW41Ti rotor (Beckman Instruments) after addition of 12% TCA in
Gee et al. • Sodium Channel Interactions with Syntrophins J. Neurosci., January 1, 1998, 18(1):128–137 129
TEE to fill the centrifuge tubes. The pellets were rinsed with 99%
ethanol, dried, and then resuspended in SDS-PAGE loading buffer.
Fusion protein affinity chromatograpy. Solubilized membranes from
mouse cardiac muscle or brain were prepared as described above. Fifty
micrograms of purified syntrophin fusion protein were added to 1 ml of
extract in 1.4 ml Eppendorf tubes along with 25 ml of S-Protein–agarose
beads and incubated overnight at 4°C on a rocker platform. After
centrifugation, the S-Protein beads were washed extensively with TEE
plus 0.5 M NaCl plus 1% Triton X-100. The final wash was removed
completely by aspirating with a flat gel-loading tip. The beads were
resuspended in 50 ml of SDS-PAGE loading buffer and heated at ;80°C
for 5 min. For peptide competition experiments, syntrophin PDZ domain
fusion proteins were preincubated with 10 mM peptide for 30 min on ice.
Immunoblotting and overlay assays. Proteins were resolved by SDS-
PAGE and transferred onto nitrocellulose membranes (Towbin et al.,
1979). The membranes were blocked with 5% skim milk powder in 25
mM Tris, pH 7.5, 150 mM NaCl, and 0.1% Tween 20 (TBS–Tween),
and then incubated with primary antibody in the same buffer for 1 hr
at room temperature. The blots were washed three times for 10 min
each in TBS–Tween, incubated with HRP-conjugated secondary anti-
body for 30 min, and finally washed another four times for 10 min each.
Immunoreactive bands were visualized by enhanced chemilumines-
cence. Overlays with biotinylated synthetic peptides were carried out
as above with the following modifications. Biotinylated peptides were
preconjugated to streptavidin–HRP as follows. Streptavidin–HRP
(0.66 mg /ml) was added to 0.1 mM peptide in blocking buffer and
incubated for 30 min at room temperature on a rocker platform. Blots
were incubated with the peptide conjugates for 1 hr and then washed
four times for 15 min each with TBS–Tween. Overlays with nNOS
were carried out as described previously (Brenman et al., 1996a). The
SkM1 and NR2B peptides were added where indicated to a final
concentration of 1 mM.
Surface plasmon resonance. The relative binding of syntrophin PDZ
domains to SKM1, SKM2, NR2B, APC, and Fas peptides was deter-
mined using surface plasmon resonance (Morelock et al., 1995; Myszka
et al., 1996). This technique has been discussed in several reviews (Fisher
and Fivash, 1994; O’Shannessy, 1994; Myszka, 1997). In brief, ligands are
attached to a carboxymethylated dextran gold surface, and analytes are
injected over the peptide surface. Binding is measured as an increase in
resonance units (RU), which directly reflect changes in refractive index
at the surface of the chip. All experiments were performed on a BIAcore
2000 instrument at the University of North Carolina Macromolecular
Interactions Facility. Neutravidin (Pierce, Rockford, IL)-coated CM5
sensor chips (BIAcore, Piscataway, NJ) were prepared to capture the
biotinylated peptides onto the surface. Neutravidin was dissolved at 1
mg/ml in 20 mM HEPES, pH 7.4, 3.4 mM EDTA, 150 mM NaCl, and
0.005% surfactant P-20 (BIAcore) (HBS). The neutravidin solution was
diluted 1:20 in 10 mM sodium acetate, pH 6.0, and then covalently
attached to the carboxyl groups on the surface of the CM5 sensor chip
activated with 200 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride and 50 mM N-hydroxysuccinimide. This was followed by 10
injections of 100 mM HCl (2 min contact time) to achieve a stable
baseline. Biotinylated NaCh peptides were immobilized by one or two
injections of 100 nM peptide onto the neutravidin surface. After injection
of 10 mM HCl to remove unbound peptide, final surface densities varied
between 75 and 125 RU.
To measure relative binding, purified syntrophin PDZ domain fusion
proteins in HBS were injected onto the peptide surfaces at a flow rate of
20 ml /min for 2 min. The steady-state binding levels, in RU, were
recorded at the end of each injection. Between successive measurements
the surfaces were regenerated by treatment with 10 mM HCl (2 min
contact time). Binding to a control blank flow cell was also measured and
used to subtract nonspecific interactions. To normalize the relative
responses to the amount of immobilized peptide, the RU values recorded
at the end of the sensorgrams were divided by the amount of each specific
peptide immobilized.
To study the inhibition of binding of a1-syntrophin PDZ domain to
nNOS by peptides, a monoclonal antibody to GST (Santa Cruz Biotech-
nology, Santa Cruz, CA) was covalently coupled to a CM5 sensor chip as
above. The GST mAb solution was diluted to 5 mg/ml in 10 mM sodium
acetate, pH 5.75, and then injected at a flow rate of 20 ml /min for 2 min.
After injection of 100 mM NaOH (5 min contact time) to remove
unbound antibody, final surface densities varied between 3000 and 10,000
RU. A 100 mg/ml solution (in HBS) of a GST fusion protein encoding
the first 299 amino acids of nNOS (Brenman et al., 1996a) was injected
onto the chip surface (1 min at a flow rate of 20 ml /min) followed by
injection of a 1 mM solution of a1-syntrophin PDZ domain fusion protein
(2 min contact time). Peptides were mixed with the a1-PDZ solution just
before injection. Between successive measurements the surface of the
chip was regenerated by treatment with 3 M MgCl2 (5 min contact time).
RESULTS
Voltage-gated NaChs are composed of a single transmembrane,
channel-forming a subunit (Mr ;250 kDa) and a variable number
of smaller (Mr ;35 kDa) transmembrane auxiliary b subunits. At
least 11 different, but homologous, genes encode the a subunits,
each of which is composed of four domains having six transmem-
brane helices each. The a subunits expressed in adult skeletal
muscle (designated SkM1) and in fetal skeletal muscle and car-
diac muscle (SkM2) have similar C termini that contain the
consensus sequence (Q/E)(S/T)XV-COOH predicted to be a
ligand for syntrophin PDZ domains (Songyang et al., 1997).
Muscle and brain NaChs copurify with syntrophins
and dystrophin
We first determined whether muscle NaChs exist in a complex
with syntrophin and dystrophin. Detergent-solubilized membrane
extracts of mouse skeletal muscle were incubated with the pan-
specific, anti-syntrophin antibody mAb 1351 coupled to Affi-
Gel-10 agarose. After extensive washing with buffer containing
0.5 M NaCl and 1% Triton X-100, bound proteins were eluted
with pH 11.5 buffer, neutralized, and resolved by SDS-PAGE.
Immunoblotting of these syntrophin preparations with a poly-
clonal antibody to a region conserved in all known NaCh a
subunits revealed a band of ;250 kDa, consistent with the size of
intact NaCh a subunit (Fig. 1A, NaCh). Preabsorption of the
NaCh antibody with the immunizing peptide eliminated this
immunoreactivity (Fig. 1A, 1pept). As expected, these prepara-
tions also contained full-length dystrophin (Kramarcy et al.,
1994) and smaller bands, which likely correspond to shorter
dystrophin isoforms (Ahn and Kunkel, 1993) (Fig. 1A, Dys).
Eluates from control mouse IgG–agarose contained no detectable
syntrophin, dystrophin, or NaCh. In the reciprocal experiment,
immunoaffinity preparations of dystrophin contained both syn-
trophin and NaCh (Fig. 1B). Collectively, these data suggest that
one or more syntrophins, dystrophin, and NaCh exist as a stable
complex in detergent extracts of skeletal muscle and, presumably
also, in situ. Similar results were also obtained with extracts of
mouse cardiac muscle and with rat skeletal and cardiac muscle
(data not shown).
Because none of the known brain NaChs contain the consensus
C-terminal sequence for binding to syntrophin PDZ domains, we
also purified syntrophins from mouse brain as a control, in the
expectation that these preparations would not contain NaChs. In
fact, they also contained NaChs as well as dystrophin (Fig. 1C).
These data suggest that syntrophins may also exist in a stable
complex with brain NaChs, presumably through interactions that
do not involve the PDZ domain.
The PDZ domain of syntrophin binds muscle, but not
brain, NaChs
To determine which domains of syntrophin are necessary for
binding to NaChs, we generated fusion proteins linking thiore-
doxin and a 15 amino acid epitope tag (S-Tag) to individual
protein domains of a1-syntrophin (Fig. 2A). The S-Tag permits
recovery and detection of fusion proteins via its interaction with
S-Protein. Approximately equal amounts of each fusion protein
were incubated with Triton X-100 extracts of mouse cardiac
muscle or brain and then isolated with S-Protein–agarose. On
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immunoblots of the eluates, bound fusion proteins were detected
using HRP-conjugated S-Protein. Approximately equal amounts
of fusion protein were captured in each case (data not shown). As
expected, cardiac muscle NaCh was captured only by the PDZ
domain fusion protein (Fig. 2B, lef t). Amounts captured by other
syntrophin domains were negligible. In several additional exper-
iments these amounts were comparable to that captured by thi-
oredoxin alone (data not shown). No NaCh was detected in
eluates from S-Protein–agarose beads alone.
Immunoblotting of the eluates from brain (Fig. 2B, right)
revealed that the fusion protein containing the a1-syntrophin
PDZ domain failed to capture NaChs, as expected. The other
three fusion proteins did, however, capture NaChs. In several
experiments the SU domain consistently bound more NaCh than
either the PH1 or PH2 domains (Fig. 2B, right). Collectively, our
results suggest that the syntrophin PDZ domain binds specifically
to the C-terminal SXV motif of muscle NaChs, whereas other
syntrophin domains contribute to the binding of brain NaChs.
The C terminus of muscle NaChs binds to the PDZ
domain of syntrophins
We next determined whether the C-terminal peptide binding
activity of PDZ domains (Doyle et al., 1996) could account for
interaction between SkM2 and syntrophin PDZ domains. Prein-
cubation of syntrophin domain fusion protein with a peptide
corresponding to the SkM2 NaCh C terminus completely blocked
the ability of the PDZ domain to capture NaCh from cardiac
extracts (Fig. 2B, lef t, lanes marked 6).
To determine whether the PDZ domains of all three syntro-
phins are capable of binding NaChs with a C-terminal SXV
motif, PDZ domain fusion proteins were used to isolate NaChs
from heart extracts. As shown in Figure 3A, all three captured
NaChs from cardiac muscle, although b1-PDZ bound significantly
less than either a1- or b2-PDZ. No NaCh was captured by
S-Protein–agarose beads alone. In a separate experiment, syn-
trophin PDZ domain fusion proteins were preincubated with a
non-SXV control peptide or a peptide corresponding to the SkM2
NaCh C terminus and then used to capture NaChs from cardiac
muscle extracts. In the presence of control peptide (Fig. 3B, lanes
C), all three syntrophin PDZ domains bound NaCh at levels
comparable to those in the absence of peptide (Fig. 3A). The
b1-PDZ domain, again, bound much less NaCh than the other
two. As found previously for a1-PDZ (Fig. 2B, lef t), preincuba-
tion with the NaCh C-terminal peptide inhibited capture of NaCh
by all three fusion proteins (Fig. 3B, lanes Na).
To determine whether the C terminus alone of NaChs is
sufficient for binding to syntrophins, biotinylated peptides corre-
sponding to the C-terminal sequences of SkM1 (VR-
PGVKESLV), SkM2 (SPDRDRESIV), and the NMDA receptor
2B subunit (NR2B; EKLSSIESDV) were coupled to streptavidi-
n–agarose and used to isolate syntrophins from cardiac muscle
extracts. Figure 4 shows that the SkM1 and SkM2 peptides bound
syntrophins well, with the SkM2 peptide binding more syntrophin
than the SkM1 peptide. In this assay, the NR2B peptide, which
also corresponds to the consensus sequence (Q/E)(S/T)XV-
COOH for syntrophin PDZ binding, bound very small amounts
of syntrophin. Streptavidin–agarose alone did not bind syntro-
phins detectably.
The results described above do not exclude the possibility that
an additional protein mediates the interaction between the NaCh
C termini and syntrophin PDZ domains. To determine whether
the interaction is direct, the biotinylated SkM1 and SkM2 pep-
Figure 1. Syntrophin, dystrophin and NaChs form a stable complex in
skeletal muscle and brain. Detergent-solubilized mouse skeletal muscle or
brain membranes were incubated with Affi-Gel-10 agarose coupled to
control mouse IgG (IgG), a pan-specific mAb to syntrophins (Syn), or an
mAb to dystrophin (Dys). Immunoaffinity-purified complexes were ana-
lyzed by immunoblotting with mAbs specific for syntrophin and dystro-
phin or with a polyclonal antibody to NaChs. Immunoblots for NaCh were
performed in the absence (NaCh), or presence (1pept) of excess immu-
nizing peptide. A, Immunoaffinity-purified syntrophin preparations con-
tain full-length dystrophin (and two shorter forms or proteolytic products
of dystrophin) and NaCh. B, Immunoaffinity-purified dystrophin com-
plexes contain both syntrophin and NaCh. C, Syntrophin preparations
from brain contain dystrophin and NaCh. The positions of molecular mass
markers (in kilodaltons) are shown at the lef t.
Gee et al. • Sodium Channel Interactions with Syntrophins J. Neurosci., January 1, 1998, 18(1):128–137 131
tides were coupled to streptavidin–HRP and used to overlay
protein blots of a1-syntrophin domain fusion proteins (Fig. 5A).
A significant fraction of all three syntrophin PDZ domain fusion
proteins consistently migrated in SDS-polyacrylamide gels as an
;60 kDa band, approximately twice the size expected. The basis
for this apparent dimerization is not known. Both peptides bound
to the PDZ domain but not to the PH1, PH2, or SU domains.
Notably, more SkM2 peptide bound to the a1-PDZ domain than
did the SkM1 peptide. A peptide corresponding to the C terminus
of Fas (NFRNEIQLSLV) (Sato et al., 1995) did not bind to any
of the domains. The NaCh peptide sequences also appear to be
specific for syntrophin PDZ domains. The SkM1 and SkM2
peptides, but not the Fas peptide, bound directly to the PDZ
domains of all three syntrophins (Fig. 5B) but did not bind to the
PDZ domain of nNOS. These data and the failure of brain NaChs
to bind to syntrophin PDZ domains suggest that the C-terminal
sequences of muscle NaCh a subunits are both necessary and
sufficient for binding to syntrophin PDZ domains.
Syntrophin PDZ domains bind preferentially to SkM2
NaCh C-terminal peptides
Relative strengths of the interactions between C-terminal S/TXV
sequences and syntrophin PDZ domains were measured using
surface plasmon resonance. The three syntrophin PDZ domains
were tested against biotinylated C-terminal peptides from the
following proteins: SkM1, SkM2, NR2B, Fas, and APC (HSG-
SYLVTSV). As shown in Figure 6, all three syntrophin PDZs
bound best to the SkM2 NaCh peptide. Each also bound the
Figure 2. The PDZ domain of a1-syntrophin captures NaChs from muscle but not brain. A, Domain organization of a1-syntrophin and position of
corresponding fusion protein constructs. a1-Syntrophin domains corresponding to those described by Adams et al. (1995) are shown drawn to scale; the first
and last amino acids in each domain are numbered. Represented below are thioredoxin fusion proteins of individual syntrophin domains containing a 15 amino
acid epitope tag (S-Tag) that binds to S-Protein. B, Affinity isolation of NaChs from mouse heart and brain with a1-syntrophin domain fusion proteins. The
indicated a1-syntrophin fusion proteins (PH1, PDZ, PH2, and SU) were incubated with detergent-solubilized membranes of mouse heart or brain, with (1)
or without (2) 10 mM SkM2 peptide, and S-Protein–agarose beads. Approximately equal amounts of each fusion protein were precipitated by the
S-Protein-agarose beads, as determined by staining with Ponceau S and by blotting with S-Protein conjugated to HRP (data not shown). The PDZ domain of
a1-syntrophin captured NaCh from heart but not from brain. Capture of NaCh from heart was inhibited completely by addition of SkM2 peptide. No NaCh
was captured by thioredoxin alone (Trx) or by S-Protein-agarose beads alone (S).
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SkM1 NaCh peptide and, interestingly, the NR2B peptide, albeit
to a lesser extent than to the SkM2 peptide. In contrast, binding
to both Fas and APC peptides was minimal, suggesting that
amino acids upstream of S/TXV may also influence binding of
these C-terminal peptides to syntrophin PDZ domains.
To address further the role of sequences upstream of S/TXV,
we used pull-down assays to determine whether syntrophin PDZ
domain fusion proteins could interact with three members of the
shaker family of K1 channels: Kv1.4 (VETDV), Kv1.1 (LLTDV),
and Kv1.2 (MLTDV). Kv1.4 has been shown previously to bind to
the second PDZ domain of PSD-95 (Kim et al., 1995). We found
that all three syntrophin PDZ domains captured substantial
amounts of Kv1.4 from detergent extracts of mouse brain mem-
branes but very little of either Kv1.1 or Kv1.2, as detected by
immunoblotting (data not shown). These results suggest that an E
at the 23 position from the C terminus of the S/TXV peptide is
important for strong syntrophin PDZ domain interaction. These
results also show that syntrophin PDZ domains can interact with
sequences with either S or T at the 22 position. A summary of the
syntrophin PDZ domain sequence preferences, based on these
findings, is presented in Figure 7.
K1 channels bind to syntrophin PDZ domains but do
not copurify with syntrophins
Because syntrophin PDZs can interact with shaker K1 channels
(especially Kv1.4; see above), we asked whether these proteins are
present in syntrophin preparations. In contrast to our results with
NaChs, we were unable to detect K1 channels in syntrophin
preparations from brain, even though we could readily detect
them in the membrane extracts (data not shown). Thus, if K1
channels exist in complexes with syntrophins in situ, the com-
plexes may be of such low affinity that they dissociate after
detergent solubilization. It is noteworthy that although syntro-
phin PDZ–K1 channel complexes did not form in the extracts
under our conditions of immunopurification, they could form
under pulldown conditions (i.e., a large excess of PDZ fusion
protein added to the extracts). From this, we conclude that the
presence of NaChs in syntrophin preparations reflects specific
complexes that exist in situ, before detergent solubilization.
The C-terminal peptide of SkM2 inhibits binding of the
a1-syntrophin PDZ domain to nNOS
The PDZ domain of a1-syntrophin and the second PDZ domain
of PSD-95 bind directly to nNOS fusion proteins containing a
PDZ domain, probably by forming PDZ–PDZ heterodimers
(Brenman et al., 1996a). Because the PDZ domain of nNOS is
internal to the protein, the interaction cannot be via C-terminal
binding. The interaction of nNOS and PSD-95 is inhibited by the
C-terminal peptide of NR2B (Brenman et al., 1996a), which
binds strongly to the second PDZ domain of PSD-95 (Kornau et
al., 1995). This suggests that the two binding reactions involve
overlapping sites or that there is strong allosteric coupling be-
tween sites. To determine whether syntrophin PDZ domains
exhibit this property, we tested NaCh C-terminal peptides for
inhibition of the binding of the a1-syntrophin PDZ domain to an
nNOS PDZ-containing fusion protein (GST–nNOS 1–299)
(Brenman et al., 1996a). First, we tested whether an NaCh
C-terminal peptide could inhibit the binding of nNOS fusion
protein to a1-PDZ in overlay assays. As shown in Figure 8A,
SkM1 peptide (1 mM) completely inhibited the binding of nNOS
to a1-PDZ. In contrast, addition of the same concentration of
either non-SXV peptides or NR2B had no effect. We also tested
the ability of the SkM1 peptide to inhibit a1-PDZ binding to
nNOS using surface plasmon resonance. GST-nNOS (1–299)
fusion protein was immobilized on a sensor chip, and a1-PDZ
was injected onto the surface of the chip. In the absence of added
peptide, injection of a1-PDZ resulted in a large increase in the
relative response, indicative of a1-PDZ binding to the nNOS
fusion protein (Fig. 8B, top trace). Addition of 1 mM peptide
decreased the observed response to approximately half of the
control response (Fig. 8B, middle trace). The response was further
reduced when 10 mM peptide was added (Fig. 8B, bottom trace).
These data demonstrate that NaChs and nNOS bind to the same
Figure 3. The C terminus is necessary for the interaction of the cardiac
muscle NaCh with the PDZ domains of a1, b1, and b2-syntrophin. A,
Affinity isolation of NaChs from heart with syntrophin PDZ domains.
Detergent-solubilized mouse heart membranes were incubated with a1-,
b1-, or b2-syntrophin PDZ domains and S-Protein–agarose. As in Figure
2, S-Protein–agarose beads pulled down approximately equal amounts of
fusion protein (data not shown). a1- and b2-PDZ pulled down roughly
equal amounts of NaCh, whereas b1-PDZ pulled down substantially less.
B, The SkM2 NaCh C-terminal peptide inhibits binding to syntrophin
PDZ domains. Syntrophin PDZ domain fusion proteins were added to
cardiac muscle membrane extracts (as in A), except that PDZ fusion
proteins were preincubated with 1 mM non-SXV control peptide (lanes C)
or a peptide corresponding to the C-terminal 10 amino acids of the SkM2
NaCh (lanes Na). The SkM2 peptide almost completely blocks the inter-
action of cardiac NaChs with syntrophin PDZ domains. As in A, a1- and
b2-PDZ pulled down roughly equal amounts of NaCh, whereas b1-PDZ
pulled down substantially less.
Figure 4. The C termini of muscle NaChs are sufficient for interaction
with syntrophins. Approximately equal amounts of biotinylated peptides
corresponding to the C-terminal 10 amino acids of the adult skeletal
(SkM1) and cardiac (SkM2) muscle NaChs and the NMDA receptor 2B
subunit (NR2B) were coupled to streptavidin–agarose beads. Detergent-
solubilized heart membranes were incubated with peptide-conjugated
beads or with beads alone (2). Bound proteins were immunoblotted for
syntrophin. Both the SkM1 and SkM2 peptides bound substantial amounts
of syntrophin, whereas NR2B bound much less.
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or overlapping sites on the PDZ domain of a1-syntrophin. Thus,
it appears unlikely that nNOS and NaChs bind simultaneously to
syntrophin PDZ domains.
DISCUSSION
We have shown that syntrophins bind to adult skeletal (SkM1)
and cardiac (SkM2) muscle NaChs. This interaction is mediated
by direct binding of the PDZ domains of syntrophins to the
(S/T)XV C terminus of these NaChs and may link NaChs to the
extracellular matrix and the cortical actin network. Formation of
this complex (Fig. 9) may be relevant to the proper localization
and physiological function of NaChs in muscle.
The C termini of the SkM1 and SkM2 NaChs are sufficient to
bind detergent-solubilized syntrophins from muscle, to inhibit the
binding of NaChs to syntrophin PDZ domain fusion proteins,
and to bind directly to syntrophin PDZ domains. To a lesser
extent, syntrophin PDZ domains also interact with Kv1.4 chan-
nels and the NMDA receptor 2B subunit. Binding to Fas or APC
C-terminal peptides was negligible. Thus, syntrophin PDZ do-
mains exhibit a high degree of specificity for C-terminal peptides
(see Fig. 7).
These results can be rationalized on the basis of the crystal
structure of a PDZ domain complexed with its cognate ligand
(Doyle et al., 1996). In the third PDZ domain of PSD-95, a loop
formed by the conserved GLGF sequence forms a hydrophobic
pocket which binds the C-terminal Val (0 position) of the peptide.
Side chains of residues at positions 22 and 23 make contacts with
side chains in the peptide-binding pocket of the PDZ domain,
whereas the side chain of the residue at position 21 points away
from the binding pocket and therefore is not predicted to influ-
ence binding. Our studies clearly demonstrate that C-terminal
SXV sequences are important for binding syntrophin PDZ do-
mains (Fig. 7). For example, brain NaChs do not bind to syntro-
phin PDZ domains but have C-terminal sequences (especially
RBSC II and RBSC VI) that are highly similar to muscle NaChs,
except that they lack a Val at the 0 position. The residue at the 23
position also appears to be essential for binding to syntrophin
PDZ domains, because all of the peptides that bound had a Glu
at this position. For example, the last three amino acids of Fas are
identical to SkM1, yet the Fas peptide, which has a Gln at the 23
position, did not bind to the PDZ domain of any of the syntro-
phins. Finally, the residue at position 24 may be important for
binding of peptides to syntrophin PDZ domains. The SkM2
NaCh peptide, which has an Arg at 24, bound approximately
fourfold better (as measured by the relative response; Fig. 6) to
syntrophin PDZs than either the SkM1 or NR2B peptides, which
have a Lys or Ile, respectively, at this position. It has been
suggested that a Lys at position 24 can bind a Glu in the loop
between the bB and bC strands of the PDZ domain (Songyang et
al., 1997), a residue conserved in the syntrophin PDZ domain.
Perhaps then, an Arg at the 24 position confers stronger binding
than a corresponding Lys. Interestingly, syntrophins contain
GLGI in place of the well conserved GLGF sequence. Our results
Figure 5. The C termini of muscle NaChs bind directly to
syntrophin PDZ domains. A, Biotinylated peptides corre-
sponding to the C-terminal 10 amino acids of the SkM1
and SkM2 NaChs or Fas bound to streptavidin–HRP were
overlaid onto a1-syntrophin domain fusion proteins. The
position and relative amount of each fusion protein was
determined by blotting with S-Protein–HRP. The asterisk
indicates the position of the PH1 fusion protein. Both the
SkM1 and SkM2 peptides bind exclusively to the PDZ
domain of a1-syntrophin, whereas the Fas peptide did not
bind to any of the domains. B, SkM1, SkM2, and Fas
C-terminal peptides were overlaid onto a1-, b1-, and b2-
syntrophin PDZ domain fusion proteins and a GST fusion
protein of nNOS (amino acids 1–150) containing the PDZ
domain (NOS). The position and relative amount of each
fusion protein were determined by blotting with S-Protein-
HRP or with an mAb to GST (Anti-GST ), followed by
donkey anti-mouse-HRP (DAM–HRP). A significant frac-
tion of all three syntrophin PDZ domain fusion proteins
migrated as dimers. SkM1 and SkM2 peptides bound to the
PDZ domains of all three syntrophins but not to the PDZ
domain of nNOS. In contrast, the Fas peptide did not bind
to any of the PDZ domains.
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demonstrate that PDZ domains containing GLGI can also bind
C-terminal peptides with an SXV consensus sequence.
A surprising result of our studies was the finding that brain
NaChs, which lack the SXV C-terminal consensus sequence, also
copurify with syntrophins. As expected, the PDZ domain of
a1-syntrophin did not bind any brain NaChs but did bind to the
SXV-containing muscle NaChs. We did find, however, that
NaChs from brain were captured by the SU and PH1 domains,
and to a lesser extent by the PH2 domain, of a1-syntrophin. The
Figure 6. Syntrophin PDZ domains bind to specific C-terminal SXV
peptides. The ability of syntrophin PDZ domain fusion proteins to bind
to SkM1, SkM2, NR2B, Fas, and APC peptides was quantitated by
surface plasmon resonance. Data for the binding of 500 nM a1-PDZ
(black bars), b1-PDZ ( gray bars), and b2-PDZ (open bars) are taken from
a single time point in the steady-state part of the binding reaction and are
the average of two separate determinations. The relative response (reso-
nance units, RU ) corresponds to the amount of fusion protein bound and
was normalized to the amount of peptide immobilized in each flow cell.
Error bars represent SEM.
Figure 7. Summary of the binding of syntrophins to C-terminal SXV
sequences. Residues in common with those in SkM1 or SkM2 are shaded.
The consensus sequence for binding to syntrophin PDZ domains is shown
below the line, with residues important for strongest binding to syntrophin
PDZ domains in bold. The methods used to conclude whether a given
sequence binds to syntrophin PDZ domains are indicated at the right. a,
Immunoaffinity copurification; b, affinity isolation with PDZ fusion pro-
teins; c, peptide overlay assays; d, surface plasmon resonance; e, peptide
affinity chromatography. RBSC, Rat brain sodium channel.
Figure 8. Competition of nNOS binding to a1-syntrophin PDZ domain
by the SkM1 NaCh C-terminal peptide. A, Purified a1-syntrophin PDZ
domain fusion protein was resolved by SDS-PAGE and transferred to a
nitrocellulose membrane. Individual lanes were incubated with a GST–
nNOS (1–299) fusion protein either alone (2) or in the presence of 1 mM
control non-SXV peptides (Control 1, 2), NR2B C-terminal peptide
(NR2B), or SkM1 C-terminal peptide (SkM1). nNOS bound to both the
monomer and dimer of a1-PDZ. Binding was almost completely blocked
by the SkM1 peptide. B, Surface plasmon resonance. GST–nNOS (1–299)
fusion protein was injected onto the surface of a sensor chip coated with
an mAb to GST, followed by injection of purified a1-syntrophin PDZ
domain fusion protein in the absence (top trace) or presence of the
indicated concentrations of SkM1 C-terminal peptide (middle and bottom
traces). Binding of a1-PDZ to GST-nNOS was measured in real time as an
increase in resonance units (RU ). One micromolar SkM1 peptide reduced
the binding by approximately half, and 10 mM peptide almost completely
inhibited the binding of a1-PDZ to nNOS (the remaining response is
attributable primarily to bulk changes in refractive index).
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SU domain consistently captured more NaCh than either the PH1
or PH2 domains. Collectively, our results suggest that other
domains in syntrophin can contribute to binding brain NaChs.
If the interaction of the PH and SU domains of syntrophin with
brain NaChs is direct, it may occur via binding to other intracel-
lular domains of NaChs. Alternatively, other proteins associated
with NaChs may mediate this interaction. The two unrelated
auxiliary b subunits of NaChs, designated b1 and b2, are possi-
bilities (Isom et al., 1992, 1995). Another possibility is ankyrin,
which copurifies with NaChs from brain (Srinivasan et al., 1988).
In skeletal muscle, ankyrin is colocalized with NaChs in the
troughs of the postjunctional folds (Flucher and Daniels, 1989); in
brain, ankyrin is colocalized with NaChs at the nodes of Ranvier
on myelinated axons (Kordeli et al., 1990). In any case, our results
suggest that NaChs in brain, like those in muscle, may be associ-
ated with the dystrophin or related proteins.
What is the functional significance of the association of NaChs
with syntrophin and dystrophin? The ability of syntrophin to link
NaChs to dystrophin and the DAPC is reminiscent of the AChR-
associated protein rapsyn. Cotransfection experiments have dem-
onstrated that rapsyn can cluster AChRs (Froehner et al., 1990;
Phillips et al., 1991; Apel et al., 1995) and a- and b-dystroglycan
(Apel et al., 1995, 1997), extracellular and transmembrane pro-
teins, respectively, of the DAPC (Ervasti and Campbell, 1991).
Thus, rapsyn may function as a link between AChRs and the
DAPC. Syntrophins may play an analogous role in the anchoring
or clustering of NaChs. Because dystrophin binds actin (Hem-
mings et al., 1992), and a-dystroglycan binds both laminin
(Ibraghimov-Beskrovnaya et al., 1992; Ervasti and Campbell,
1993; Gee et al., 1993) and agrin (Bowe et al., 1994; Campanelli
et al., 1994; Gee et al., 1994; Sugiyama et al., 1994), the interac-
tion with syntrophins may be sufficient to link NaChs to the
cortical actin network and the extracellular matrix. Consistent
with this idea, CHO cells expressing a neural agrin isoform can
cluster NaChs at points of contact with muscle cells (Sharp and
Caldwell, 1996).
Finally, syntrophins may modulate the function of NaChs.
Evidence supporting such a notion is the recent demonstration
that the interaction of the SXV-containing C terminus of the K1
channel a subunit Kv1.1 with the cytoskeleton regulates the
extent of inactivation conferred by the b subunit (Jing et al.,
1997). Such functional changes may be especially important when
considering myopathies such as DMD. For example, patients with
DMD suffer from conduction disturbances and heart block, sug-
gesting an important role for dystrophin in the cardiac conduction
system (Bies et al., 1992). The finding that syntrophin links
NaChs to dystrophin provides a plausible explanation for these
defects; a reduction in sarcolemmal syntrophin may lead to aber-
rant NaCh distribution or function in cardiac cells. Our results,
taken together, emphasize the importance of syntrophins as mul-
tidomain scaffolds that link NaChs to the DAPC and, hence, to
the actin cytoskeleton and the extracellular matrix.
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